Home - Products - Angiogenesis - PDE - (+)-Medioresinol Di-O-β-D-glucopyranoside

(+)-Medioresinol Di-O-β-D-glucopyranoside

CAS No. 88142-63-6

(+)-Medioresinol Di-O-β-D-glucopyranoside( (+)-Medioresinol Di-O-β-D-glucopyranoside )

Catalog No. M29323 CAS No. 88142-63-6

(+)-Medioresinol Di-O-β-D-glucopyranoside has strong inhibitory activity of cyclic AMP phosphodiesterase.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 839 Get Quote
10MG 1143 Get Quote
25MG 1692 Get Quote
50MG 2277 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    (+)-Medioresinol Di-O-β-D-glucopyranoside
  • Note
    Research use only, not for human use.
  • Brief Description
    (+)-Medioresinol Di-O-β-D-glucopyranoside has strong inhibitory activity of cyclic AMP phosphodiesterase.
  • Description
    (+)-Medioresinol Di-O-β-D-glucopyranoside has strong inhibitory activity of cyclic AMP phosphodiesterase.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (+)-Medioresinol Di-O-β-D-glucopyranoside
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    88142-63-6
  • Formula Weight
    712.69
  • Molecular Formula
    C33H44O17
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O(C)C=1C=C([C@@]2([C@@]3([C@@]([C@](OC3)(C4=CC(OC)=C(O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C=C4)[H])(CO2)[H])[H])[H])C=C(OC)C1O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Lirimilast

    Lirimilast (BAY 19-8004;BAY 198004) is a potent and selective PDE4 inhibitor for the treatment of COPD.

  • BPN14770 (b)

    BPN14770 (BPN-14770) is an allosteric inhibitor of phosphodiesterase 4D (PDE4D) with IC50 of 7.8 and 7.4 nM for human PDE4D7 and PDE4D3 respectively.

  • Tofimilast

    Tofimilast (CP-325366) is a potent, selective PDE4 inhibitor with IC50 of 23, 13 and 13 nM for PDE4A, PDE4B, and PDE4D, respectively.